-
1
-
-
0032782622
-
Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression
-
R Ouatu-Lascar RC Fitzgerald G Triadafilopoulos Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression Gastroenterology 117 1999 327 335
-
(1999)
Gastroenterology
, vol.117
, pp. 327-335
-
-
Ouatu-Lascar, R1
Fitzgerald, RC2
Triadafilopoulos, G3
-
2
-
-
0029907124
-
Dynamic effects of acid on Barrett's esophagus: an ex vivo proliferation and differentiation model
-
RC Fitzgerald MB Omary G Triadafilopoulos Dynamic effects of acid on Barrett's esophagus: an ex vivo proliferation and differentiation model J Clin Invest 98 1996 2120 2128
-
(1996)
J Clin Invest
, vol.98
, pp. 2120-2128
-
-
Fitzgerald, RC1
Omary, MB2
Triadafilopoulos, G3
-
3
-
-
0028216695
-
Successful elimination of reflux symptoms does not ensure adequate control of acid reflux in Barrett's esophagus
-
DA Katzka DO Castell Successful elimination of reflux symptoms does not ensure adequate control of acid reflux in Barrett's esophagus Am J Gastroenterol 89 1994 989 991
-
(1994)
Am J Gastroenterol
, vol.89
, pp. 989-991
-
-
Katzka, DA1
Castell, DO2
-
4
-
-
0032081061
-
Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal acid reflux in patients with Barrett's esophagus
-
R Ouatu-Lascar G Triadafilopoulos Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal acid reflux in patients with Barrett's esophagus Am J Gastroenterol 93 1998 711 716
-
(1998)
Am J Gastroenterol
, vol.93
, pp. 711-716
-
-
Ouatu-Lascar, R1
Triadafilopoulos, G2
-
6
-
-
0030947026
-
Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus
-
P Sharma RE Sampliner E Camargo Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus Am J Gastroenterol 92 1997 582 585
-
(1997)
Am J Gastroenterol
, vol.92
, pp. 582-585
-
-
Sharma, P1
Sampliner, RE2
Camargo, E3
-
7
-
-
0029738349
-
Optimal dosing of omeprazole 40 mg daily: effects on gastric and esophageal pH and serum gastrin in healthy controls
-
B Kuo DO Castell Optimal dosing of omeprazole 40 mg daily: effects on gastric and esophageal pH and serum gastrin in healthy controls Am J Gastroenterol 91 1996 1532 1538
-
(1996)
Am J Gastroenterol
, vol.91
, pp. 1532-1538
-
-
Kuo, B1
Castell, DO2
-
8
-
-
0031787618
-
Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: a controlled study in normal subjects
-
PL Peghini PO Katz DO Castell Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: a controlled study in normal subjects Gastroenterology 115 1998 1335 1339
-
(1998)
Gastroenterology
, vol.115
, pp. 1335-1339
-
-
Peghini, PL1
Katz, PO2
Castell, DO3
|